Asthmapolis has won the Twilio + Union Square Ventures contest with its innovative tool for tracking, managing, and researching asthma using SMS technology. The service allows patients to record and track their symptoms, triggers, and medication use, providing valuable data for better management and public health awareness. Asthmapolis aims to empower individuals to control their asthma by collecting accurate data, creating awareness, and providing feedback to patients, healthcare providers, and public health officials. The platform has a broad availability due to the widespread use of cell phones, making it an appealing tool for health tracking and disease management. The team behind Asthmapolis plans to expand its services through multiple interfaces and explore business models for aggregated data on asthma incidence. They are looking forward to discussing go-to-market strategies and scaling with the partnership at Union Square Ventures.